203 related articles for article (PubMed ID: 11745403)
1. Rationally designed strings of promiscuous CD4(+) T cell epitopes provide help to Haemophilus influenzae type b oligosaccharide: a model for new conjugate vaccines.
Falugi F; Petracca R; Mariani M; Luzzi E; Mancianti S; Carinci V; Melli ML; Finco O; Wack A; Di Tommaso A; De Magistris MT; Costantino P; Del Giudice G; Abrignani S; Rappuoli R; Grandi G
Eur J Immunol; 2001 Dec; 31(12):3816-24. PubMed ID: 11745403
[TBL] [Abstract][Full Text] [Related]
2. Polysaccharide conjugate vaccine protein carriers as a "neglected valency" - Potential and limitations.
Bröker M; Berti F; Schneider J; Vojtek I
Vaccine; 2017 Jun; 35(25):3286-3294. PubMed ID: 28487056
[TBL] [Abstract][Full Text] [Related]
3. Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine.
Panpitpat C; Thisyakorn U; Chotpitayasunondh T; Fürer E; Que JU; Hasler T; Cryz SJ
Bull World Health Organ; 2000; 78(3):364-71. PubMed ID: 10812736
[TBL] [Abstract][Full Text] [Related]
4. Development of a guinea-pig model for potency/immunogenicity evaluation of diphtheria, tetanus acellular pertussis (DTaP) and Haemophilus influenzae type b polysaccharide conjugate vaccines.
Gupta RK; Anderson R; Cecchini D; Rost B; Griffin P; Benscoter K; Xu J; Montanez-Ortiz L; Siber GR
Dev Biol Stand; 1996; 86():283-96. PubMed ID: 8785957
[TBL] [Abstract][Full Text] [Related]
5. Suppression and modulation of cellular and humoral immune responses to Haemophilus influenzae type B (Hib) conjugate vaccine in hib-diphtheria-tetanus toxoids-acellular pertussis combination vaccines: a study in a rat model.
Mawas F; Newman G; Burns S; Corbel MJ
J Infect Dis; 2005 Jan; 191(1):58-64. PubMed ID: 15593004
[TBL] [Abstract][Full Text] [Related]
6. Haemophilus influenzae type b-outer membrane protein complex glycoconjugate vaccine induces cytokine production by engaging human toll-like receptor 2 (TLR2) and requires the presence of TLR2 for optimal immunogenicity.
Latz E; Franko J; Golenbock DT; Schreiber JR
J Immunol; 2004 Feb; 172(4):2431-8. PubMed ID: 14764714
[TBL] [Abstract][Full Text] [Related]
7. Randomised trial of the effect of co-administration with acellular pertussis DTP vaccine on immunogenicity of Haemophilus influenzae type b conjugate vaccine.
Eskola J; Olander RM; Hovi T; Litmanen L; Peltola S; Käyhty H
Lancet; 1996 Dec 21-28; 348(9043):1688-92. PubMed ID: 8973430
[TBL] [Abstract][Full Text] [Related]
8. Safety and immunogenicity of a Haemophilus influenzae type B polysaccharide-tetanus toxoid conjugate vaccine combined with diphtheria, tetanus and pertussis vaccines in Thai infants.
Chotpitayasunondh T; Panpitpat C; Thisyakorn U; Furer E; Que JU; Hasler T; Cryz SJ
Southeast Asian J Trop Med Public Health; 1997 Mar; 28(1):91-8. PubMed ID: 9322290
[TBL] [Abstract][Full Text] [Related]
9. Haemophilus influenzae type b immunization in infants in the United Kingdom: effects of diphtheria/tetanus/acellular pertussis/Hib combination vaccine, significant prematurity, and a fourth dose.
Berrington JE; Cant AJ; Matthews JN; O'Keeffe M; Spickett GP; Fenton AC
Pediatrics; 2006 Apr; 117(4):e717-24. PubMed ID: 16549502
[TBL] [Abstract][Full Text] [Related]
10. Combined conjugate vaccines: enhanced immunogenicity with the N19 polyepitope as a carrier protein.
Baraldo K; Mori E; Bartoloni A; Norelli F; Grandi G; Rappuoli R; Finco O; Del Giudice G
Infect Immun; 2005 Sep; 73(9):5835-41. PubMed ID: 16113302
[TBL] [Abstract][Full Text] [Related]
11. Glycoconjugate vaccines and immune interference: A review.
Dagan R; Poolman J; Siegrist CA
Vaccine; 2010 Aug; 28(34):5513-23. PubMed ID: 20600514
[TBL] [Abstract][Full Text] [Related]
12. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.
Granoff DM; Holmes SJ; Belshe RB; Osterholm MT; McHugh JE; Anderson EL
JAMA; 1994 Oct; 272(14):1116-21. PubMed ID: 7933324
[TBL] [Abstract][Full Text] [Related]
13. N19 polyepitope as a carrier for enhanced immunogenicity and protective efficacy of meningococcal conjugate vaccines.
Baraldo K; Mori E; Bartoloni A; Petracca R; Giannozzi A; Norelli F; Rappuoli R; Grandi G; Del Giudice G
Infect Immun; 2004 Aug; 72(8):4884-7. PubMed ID: 15271954
[TBL] [Abstract][Full Text] [Related]
14. Interchangeability of conjugated Haemophilus influenzae type b vaccines in infants.
Anderson EL; Decker MD; Englund JA; Edwards KM; Anderson P; McInnes P; Belshe RB
JAMA; 1995 Mar; 273(11):849-53. PubMed ID: 7869554
[TBL] [Abstract][Full Text] [Related]
15. Synthetic oligodeoxynucleotide containing CpG motif induces an anti-polysaccharide type 1-like immune response after immunization of mice with Haemophilus influenzae type b conjugate vaccine.
von Hunolstein C; Teloni R; Mariotti S; Recchia S; Orefici G; Nisini R
Int Immunol; 2000 Mar; 12(3):295-303. PubMed ID: 10700464
[TBL] [Abstract][Full Text] [Related]
16. Mutual interactions between DTaP-IPV and Haemophilus influenzae type b (Hib)-conjugated vaccines in laboratory animal models.
Shams H; Heron I
Biologicals; 1999 Sep; 27(3):227-40. PubMed ID: 10652178
[TBL] [Abstract][Full Text] [Related]
17. The development of a new heptavalent diphtheria-tetanus-whole cell pertussis-hepatitis B-Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C vaccine: a randomized dose-ranging trial of the conjugate vaccine components.
Gatchalian S; Palestroque E; De Vleeschauwer I; Han HH; Poolman J; Schuerman L; Dobbelaere K; Boutriau D
Int J Infect Dis; 2008 May; 12(3):278-88. PubMed ID: 17981067
[TBL] [Abstract][Full Text] [Related]
18. Reactogenicity and immunogenicity profiles of a novel pentavalent diphtheria-tetanus-whole cell pertussis-hepatitis B and Haemophilus influenzae type B vaccine: a randomized dose-ranging trial of the Hib tetanus-conjugate content.
Hla KH; Thein SA; Aye A; Han HH; Bock HL; David MP; Schuerman L
Pediatr Infect Dis J; 2006 Aug; 25(8):706-12. PubMed ID: 16874170
[TBL] [Abstract][Full Text] [Related]
19. Combination of DTP and Haemophilus influenzae type b conjugate vaccines can affect laboratory evaluation of potency and immunogenicity.
Redhead K; Sesardic D; Yost SE; Attwell AM; Watkins J; Hoy CS; Plumb JE; Corbel MJ
Biologicals; 1994 Dec; 22(4):339-45. PubMed ID: 7779360
[TBL] [Abstract][Full Text] [Related]
20. Immunogenicity and safety of a fully liquid aluminum phosphate adjuvanted Haemophilus influenzae type b PRP-CRM197-conjugate vaccine in healthy Japanese children: A phase III, randomized, observer-blind, multicenter, parallel-group study.
Togashi T; Mitsuya N; Kogawara O; Sumino S; Takanami Y; Sugizaki K
Vaccine; 2016 Aug; 34(38):4635-4641. PubMed ID: 27265451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
